These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 12829913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
    Engelmann I, Welte T, Fühner T, Simon AR, Mattner F, Hoy L, Schulz TF, Gottlieb J.
    J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
    Valentine VG, Weill D, Gupta MR, Raper B, Laplace SG, Lombard GA, Bonvillain RW, Taylor DE, Dhillon GS.
    J Heart Lung Transplant; 2008 Aug; 27(8):875-81. PubMed ID: 18656801
    [Abstract] [Full Text] [Related]

  • 5. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.
    Ruttmann E, Geltner C, Bucher B, Ulmer H, Höfer D, Hangler HB, Semsroth S, Margreiter R, Laufer G, Müller LC.
    Transplantation; 2006 May 27; 81(10):1415-20. PubMed ID: 16732179
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G, Baldanti F, Torsellini M, Minoli L, Viganò M, Oggionnis T, Rampino T, Castiglioni B, Goglio A, Colledan M, Mammana C, Nozza F, Daniele L, Bergamo Transplant Group.
    Antivir Ther; 2007 May 27; 12(1):63-72. PubMed ID: 17503749
    [Abstract] [Full Text] [Related]

  • 7. Extended ganciclovir prophylaxis in lung transplantation.
    Perreas KG, McNeil K, Charman S, Sharples LD, Wreghitt T, Wallwork J.
    J Heart Lung Transplant; 2005 May 27; 24(5):583-7. PubMed ID: 15896756
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J.
    J Heart Lung Transplant; 1998 Dec 27; 17(12):1255-63. PubMed ID: 9883768
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Manuel O, Kumar D, Moussa G, Chen MH, Pilewski J, McCurry KR, Studer SM, Crespo M, Husain S, Humar A.
    Transplantation; 2009 Mar 15; 87(5):719-25. PubMed ID: 19295317
    [Abstract] [Full Text] [Related]

  • 14. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.
    Soghikian MV, Valentine VG, Berry GJ, Patel HR, Robbins RC, Theodore J.
    J Heart Lung Transplant; 1996 Sep 15; 15(9):881-7. PubMed ID: 8889983
    [Abstract] [Full Text] [Related]

  • 15. Infections in lung allograft recipients: ganciclovir era.
    Valentine VG, Bonvillain RW, Gupta MR, Lombard GA, LaPlace SG, Dhillon GS, Wang G.
    J Heart Lung Transplant; 2008 May 15; 27(5):528-35. PubMed ID: 18442719
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT, Alba A, Sepúlveda C.
    Transplant Proc; 2010 May 15; 42(1):331-2. PubMed ID: 20172344
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM, Iversen M, Mortensen J, Carlsen J, Andersen CB, Milman N, Scheike T.
    J Heart Lung Transplant; 2007 Nov 15; 26(11):1127-34. PubMed ID: 18022078
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP.
    J Heart Lung Transplant; 1998 Sep 15; 17(9):869-75. PubMed ID: 9773858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.